BiotechTube
Home/ArrePath/Alita Miller, Ph. D.
AM

Alita Miller, Ph. D.

Chief Scientific Officer

ArrePath

Therapeutic Areas

Infectious DiseasesRespiratory Medicine

ArrePath Pipeline

DrugIndicationPhase
Novel Antibiotic Class 1Bacterial InfectionsPre-clinical
Novel Antibiotic Class 2Bacterial InfectionsPre-clinical
NTM ProgramNon-Tuberculous Mycobacterial InfectionsPre-clinical
Respiratory Medicine ProgramUndisclosed Respiratory DiseaseDiscovery

Leadership Team at ArrePath

KK
Kevin Krause
President and Chief Executive Officer
View full ArrePath profile